Valuation: InterCure Ltd.

Market Cap 14Cr 0 12Cr 11Cr 11Cr 20Cr 1.37TCr 20Cr 135.77Cr 53Cr 689.12Cr 54Cr 53Cr 2.28TCr P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 28Cr 0 24Cr 22Cr 21Cr 39Cr 2.68TCr 39Cr 264.87Cr 103.29Cr 1.34TCr 105.03Cr 102.74Cr 4.45TCr EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+1.67%
1 week-6.89%
Current month-16.76%
1 month-7.02%
3 months+4.21%
6 months-6.09%
Current year-18.97%
1 week 251
Extreme 251
291.7
1 month 251
Extreme 251
315
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
570
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Chairman 55 13/02/2025
Director/Board Member 65 01/11/2020
Director/Board Member 66 14/12/2014
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

15,000 0.0274%
09/11/22 Option

Chief Financial Officer

2,30,000 0.5066%
09/11/22 Option 2,30,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%-6.89%-52.71%-53.40% 4.8Cr
+5.84%+7.51%-5.56%+197.92% 33Cr
+3.01%+1.18%-21.20%-15.76% 17Cr
+0.51%+0.51%+6.42%+84.26% 14Cr
+2.17%+11.90%-27.69%-14.55% 9.55Cr
0.00%+5.36%+13.46%+28.26% 5.31Cr
Average +2.20%+3.26%-14.55%+37.79% 14.11Cr
Weighted average by Cap. +3.34%+4.57%-10.74%+85.80%

Financials

2024 2025
Net sales 24Cr 0 20Cr 19Cr 18Cr 33Cr 2.29TCr 33Cr 226.17Cr 88Cr 1.15TCr 90Cr 88Cr 3.8TCr 27Cr 0 23Cr 22Cr 20Cr 37Cr 2.59TCr 38Cr 255.87Cr 100Cr 1.3TCr 101.46Cr 99Cr 4.3TCr
Net income -6.78Cr -0 -5.81Cr -5.43Cr -4.97Cr -9.33Cr -648.66Cr -9.46Cr -64Cr -25Cr -325.85Cr -25Cr -25Cr -1.08TCr -3.57Cr -0 -3.06Cr -2.86Cr -2.62Cr -4.92Cr -341.67Cr -4.98Cr -34Cr -13Cr -171.64Cr -13Cr -13Cr -567.7Cr
Net Debt 13Cr 0 11Cr 11Cr 9.74Cr 18Cr 1.27TCr 19Cr 125.71Cr 49Cr 638.07Cr 50Cr 49Cr 2.11TCr 14Cr 0 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 129.1Cr 50Cr 655.3Cr 51Cr 50Cr 2.17TCr
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
21/26/21 ILA 262.20 +1.67% 56,895
20/26/20 ILA 257.90 -2.86% 1,11,566
19/26/19 ILA 265.50 -6.28% 1,55,958
18/26/18 ILA 283.30 -0.49% 12,373
17/26/17 ILA 284.70 +1.10% 27,204
  1. Stock Market
  2. Stocks
  3. INCR Stock